| UCB S.A. |
| Belgien |
| Gesundheit |
| BE0003739530 / 852738 |
| UNC (Frankfurt) |
| FRA:UNC, ETR:UNC, UNC:GR |
| - |
| https://www.ucb.com/ |
|
UCB SA is a multinational biopharmaceutical company headquartered in Brussels, Belgium, founded in 1928 by Emmanuel Janssen. It specializes in developing innovative medicines for severe neurological and immunological diseases, including epilepsy, Par..
>Volltext.. |
| 45101.38 Mio. EUR |
| 44876.11 Mio. EUR |
| 7964.16 Mio. EUR |
| 2711.99 Mio. EUR |
| 1602.91 Mio. EUR |
| 8.43 EUR |
| 2309.72 Mio. EUR |
| 2315.89 Mio. EUR |
| 2225.35 Mio. EUR |
| 0.56 |
| 25.83% |
| 46.29% |
| 1.45 EUR |
| 0.41% |
| 0.41% |
| 04.05.26 - 1.45€ 25.04.25 - 1.39€ >weitere anzeigen... |
| - |
| UCB |
| 13.07.26 |
|
||||
|